Clinical characteristics of patients with connective tissue disease –related interstitial lung disease: a retrospective analysis

ConclusionsAs a critical manifestation of connective tissue diseases, immunosuppressive treatment is indispensable in the management of interstitial lung diseases especially those at an increased risk for progression. The treatment approaches should be assessed in a patient-based way. The patients under immunosuppressive treatment should be cautiously followed for infections.Key Points•Interstitial lung disease is a noteworthy manifestation of connective tissue diseases.•The clinical findings, treatment requirements, and progression vary according to the severity of the disease.•Immunosuppressive treatment may be essential in patients with worsening symptoms, impaired pulmonary function tests, and radiological findings.
Source: Clinical Rheumatology - Category: Rheumatology Source Type: research